Aortic Valve Disorder Clinical Trial
Official title:
Transcatheter Aortic Valve Intervention-Live Transmission (VERITAS)Study
The primary objective of this clinical trial is to evaluate safety of patients who underwent Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission as compared to those without procedure transmission.
A series of sites from outside the US, where the Edwards-Sapien and CoreValve devices are approved for commercial sale and implantation, will be recruited to retrospectively identify and extract in-hospital data of a patient who underwent TAVI during a live or video-taped procedure and a matched patient who underwent TAVI without transmission of the procedure. ;
Observational Model: Case Control, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02910349 -
Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation
|
||
Completed |
NCT03298932 -
2D Strain of Right Ventricle in Peroperative of Cardiac Surgery
|
||
Completed |
NCT01171625 -
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
|
N/A | |
Completed |
NCT01959503 -
Progel Vascular Sealant
|
N/A | |
Completed |
NCT03016169 -
Trifectaâ„¢ GT Post Market Clinical Follow-up
|
N/A | |
Terminated |
NCT02678871 -
Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
|
N/A | |
Suspended |
NCT01536717 -
Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery
|
Phase 4 | |
Completed |
NCT00934596 -
CO2 Versus Lund De-airing Technique in Heart Surgery
|
N/A | |
Completed |
NCT01651052 -
Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000
|
N/A | |
Terminated |
NCT02696226 -
Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
|
N/A | |
Completed |
NCT01619982 -
Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients
|
Phase 4 |